The European Union’s medicines authority says it has begun evaluating a new drug for treating COVID-19 patients who do not require extra oxygen but are at increased risk of developing severe symptoms of the disease
Related posts
-
Arlington Heights hires traffic expert in anticipation of Bears plans
Arlington Heights officials signed a new contract with a traffic consultant to review the Bears’ studies... -
Des Plaines council cutting city clerk’s oversight of staff
A divided Des Plaines City Council on Monday tentatively eliminated the city clerk’s authority over the... -
Trump hits ‘pause’ on U.S. aid to Ukraine
President Donald Trump on Monday directed a "pause" to U.S. assistance to Ukraine after a disastrous...